Io Biotech, Inc. (IOBT) — SC 13D/A Filings
All SC 13D/A filings from Io Biotech, Inc.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Novo Holdings Amends IO Biotech Stake
— Sep 17, 2024 Risk: medium
Novo Holdings A/S has amended its Schedule 13D filing for IO Biotech, Inc. on September 17, 2024. The filing indicates a change in beneficial ownership, though -
Novo Holdings Amends IO Biotech Stake Disclosure
— Feb 13, 2024 Risk: low
Novo Holdings A/S filed an Amendment No. 4 to its Schedule 13D (SC 13D/A) on February 13, 2024, concerning its beneficial ownership of Common Stock, par value $
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX